We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.51%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.52B
AUM Growth
+$1.2B
Cap. Flow
+$726M
Cap. Flow %
9.65%
Top 10 Hldgs %
19.11%
Holding
866
New
79
Increased
318
Reduced
279
Closed
56

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$75M
2
BIIB icon
Biogen
BIIB
+$70.7M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$60.1M
4
MRK icon
Merck
MRK
+$54.6M
5
GILD icon
Gilead Sciences
GILD
+$33.1M

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$19.1M
2
IRBT
iRobot
IRBT
+$15.5M
3
DGX icon
Quest Diagnostics
DGX
+$15.4M
4
CL icon
Colgate-Palmolive
CL
+$14.8M
5
PM icon
Philip Morris
PM
+$12.3M

Sector Composition

Rank Sector Weight
1 Healthcare 33.26%
2 Technology 16.05%
3 Financials 11.26%
4 Consumer Discretionary 7.98%
5 Communication Services 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KO icon
101
Coca-Cola
KO
$354B
$18.1M 0.24%
392,643
+38,211
+11% +$1.75M
ELV icon
102
Elevance Health
ELV
$81.9B
$18M 0.24%
65,627
-15,501
-19% -$4.02M
TJX icon
103
TJX Companies
TJX
$170B
$17.6M 0.23%
313,500
+13,226
+4% +$679K
LLY icon
104
Eli Lilly
LLY
$1.07T
$17.4M 0.23%
162,081
-102,872
-39% -$10.3M
ONC
105
BeOne Medicines Ltd
ONC
$33.8B
$17.3M 0.23%
100,300
+58,800
+142% +$9.89M
MS icon
106
Morgan Stanley
MS
$337B
$17.1M 0.23%
366,749
+135,549
+59% +$6.62M
MMM icon
107
3M
MMM
$89B
$16.8M 0.22%
95,314
+10,825
+13% +$1.86M
TAL icon
108
TAL Education Group
TAL
$5.71B
$16.6M 0.22%
646,500
-363,800
-36% -$11.8M
TECH icon
109
Bio-Techne
TECH
$11.2B
$16.5M 0.22%
322,800
+120,400
+59% +$5.33M
ATVI
110
DELISTED
Activision Blizzard
ATVI
$16.5M 0.22%
197,913
+113,913
+136% +$8.64M
CL icon
111
Colgate-Palmolive
CL
$72.6B
$16.4M 0.22%
244,767
-222,225
-48% -$14.8M
RETA
112
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$16M 0.21%
195,200
+48,500
+33% +$3.42M
APD icon
113
Air Products & Chemicals
APD
$66.3B
$15.9M 0.21%
95,289
+61,620
+183% +$10M
DD icon
114
DuPont de Nemours
DD
$18.6B
$15.8M 0.21%
96,716
-4,154
-4% -$715K
BHVN
115
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$15.7M 0.21%
417,299
+210,200
+101% +$7.73M
ITW icon
116
Illinois Tool Works
ITW
$81.4B
$15.3M 0.2%
108,629
+76,858
+242% +$10.8M
PTCT icon
117
PTC Therapeutics
PTCT
$6.37B
$15.3M 0.2%
325,523
+169,523
+109% +$7.01M
BLUE
118
DELISTED
bluebird bio
BLUE
$15.1M 0.2%
7,998
+2,934
+58% +$6.06M
CBRE icon
119
CBRE Group
CBRE
$40.8B
$15.1M 0.2%
342,223
-68,122
-17% -$3.25M
MA icon
120
Mastercard
MA
$477B
$14.8M 0.2%
66,421
-51,594
-44% -$10.8M
MCD icon
121
McDonald's
MCD
$188B
$14.8M 0.2%
88,351
-2,360
-3% -$378K
BDX icon
122
Becton Dickinson
BDX
$43.1B
$14.7M 0.2%
57,623
+3,657
+7% +$901K
BEN icon
123
Franklin Resources
BEN
$16.9B
$14.5M 0.19%
476,764
+21,378
+5% +$689K
PBYI icon
124
Puma Biotechnology
PBYI
$406M
$14.5M 0.19%
316,200
+211,200
+201% +$10.2M
MNST icon
125
Monster Beverage
MNST
$91.4B
$14.4M 0.19%
493,892
+27,568
+6% +$829K
3 4
5
6 7

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2018 Portfolio in Review

As of Q3 2018, Candriam SCA held 866 positions worth $7.52B, up 19% from $6.32B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Candriam SCA deployed $726M of net new capital in Q3 2018, opening 79 new positions and adding to 318 existing holdings. Its largest new stake was Varonis Systems: 541,092 shares worth $13.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 25% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Advanced Micro Devices, an estimated $19.1M trimmed.

  • Candriam SCA's largest Q3 2018 buy was Varonis Systems: 541,092 shares worth $13.2M.
  • Candriam SCA added most to Amgen in Q3 2018, an estimated $75M increase.
  • Candriam SCA's biggest Q3 2018 reduction was Advanced Micro Devices, cutting an estimated $19.1M.
  • Candriam SCA fully exited iRobot in Q3 2018, selling an estimated $15.5M.
  • Candriam SCA's ten largest holdings make up 19% of its $7.52B portfolio in Q3 2018.
  • Candriam SCA opened 79 new positions and closed 56 in Q3 2018.
  • Candriam SCA's portfolio value rose 19% quarter-over-quarter to $7.52B.

Based on Candriam SCA's 13F filing for Q3 2018, filed 7 Nov 2018.